炎症与动脉粥样硬化

被引:25
作者
沈彬
机构
[1] 第二军医大学长征医院心血管内科上海
关键词
动脉粥样硬化; 冠心病; 炎症反应;
D O I
暂无
中图分类号
R543.5 [动脉疾病];
学科分类号
1002 ; 100201 ;
摘要
冠状动脉粥样硬化是冠心病的病理基础 ,近年来的研究表明 ,炎症在动脉粥样硬化 (AS)斑块的发生、演变及破裂过程中有至关重要的作用。本文主要对炎症反应在AS的触发因素、可能的调控机制及血清学标志物、抗炎治疗等方面在近年来的研究进展作一综述
引用
收藏
页码:66 / 70
页数:5
相关论文
共 27 条
[1]  
Nuclear factor-kappa B is selectively and markedly activated in humans with unstable angina pectoris. Ritchie ME. Circulation . 1998
[2]  
Effect of statin therapy on C- reactive protein levels.The Pravastatin Inflammation/CRP Evaluation(PRINCE): a randomized trial and cohort study. Albert MA,Danielson E,Rifai N,et al. The Journal of The American Medical Association . 2001
[3]  
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Li D,saldeen T,Romeo F,et al. Circulation . 2000
[4]  
Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease. Mehta JL,Romeo F. Drugs . 2000
[5]  
Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Espinola-Klein C,Rupprecht HJ,Blankenberg S,et al. Circulation . 2002
[6]  
C-reactive protein in healthy subjects:associations with obesity,insulin resistance,and endothelial dysfunction:a potential role for cytokines originating from adipose tissue. YudkinJS,StehouwerCD,EmeisJJ,etal. Arteriosclerosis and Thrombosis . 1999
[7]  
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Schmidt AM,Yan SD,Wautier JL,et al. Circulation Research . 1999
[8]  
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Schieffer B,Schieffer E,Hilfiker-Kleiner D,et al. Circulation . 2000
[9]  
Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Kranzhofer R,Schmidt J,Pfeiffer CA,et al. Arteriosclerosis and Thrombosis . 1999
[10]  
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. Ridker PM,Rifai N,Clearfield M,et al. The New England Journal of Medicine . 2001